The Discounted Cash Flow (DCF) valuation of Kilitch Drugs (India) Ltd (KILITCH.NS) is 101.34 INR. With the latest stock price at 433.95 INR, the upside of Kilitch Drugs (India) Ltd based on DCF is -76.6%.
Based on the latest price of 433.95 INR and our DCF valuation, Kilitch Drugs (India) Ltd (KILITCH.NS) is a sell. selling KILITCH.NS stocks now will result in a potential gain of 76.6%.
| Range | Selected | |
| WACC / Discount Rate | 12.3% - 15.8% | 14.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 73.78 - 149.75 | 101.34 |
| Upside | -83.0% - -65.5% | -76.6% |